Ngā hua rapu kaituhi

1

Toll-like Receptor 4 in COVID-19: Friend Or foe? mā Suprabhat Mukherjee

I whakaputaina 2022

Whiwhi kuputuhi katoa
Editorial

Tiaki ki tētahi rārangi

I tiakina i:
2

In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs mā Abhigyan Choudhury, Suprabhat Mukherjee

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Targeting human TLRs to combat COVID‐19: A solution? mā Ritwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee

I whakaputaina 2020

Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
4

Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics Approach mā Ritwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma mā Ritwik Patra, Amit Kumar Dey, Suprabhat Mukherjee

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review mā Suprabhat Mukherjee, Subhajit Karmakar, Santi P. Sinha Babu

I whakaputaina 2016

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Toll‐like receptor polymorphism in host immune response to infectious diseases: A review mā Suprabhat Mukherjee, Sahel Huda, Santi P. Sinha Babu

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein mā Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings mā Suprabhat Mukherjee, Nikhilesh Joardar, Subhasree Sengupta, Santi P. Sinha Babu

I whakaputaina 2018

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

DPP-4 Inhibitors as a Savior for COVID-19 Patients with Diabetes mā Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu

I whakaputaina 2023

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

Andrographolide Induces anti-SARS-CoV-2 Response Through host-directed Mechanism: an <i>in silico</i> Study mā B. S. Das, Nabarun Chandra Das, Shasank S. Swain, Suprabhat Mukherjee, Debapriya Bhattacharya

I whakaputaina 2022

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Wuchereria bancrofti filaria activates human dendritic cells and polarizes T helper 1 and regulatory T cells via toll-like receptor 4 mā Suprabhat Mukherjee, Anupama Karnam, Mrinmoy Das, Santi P. Sinha Babu, Jagadeesh Bayry

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives mā Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, Andrea Masotti, Alessandro Paolini, Meysam Sarshar

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

A Novel Ligand of Toll-like Receptor 4 From the Sheath of Wuchereria bancrofti Microfilaria Induces Proinflammatory Response in Macrophages mā Suprabhat Mukherjee, Sandip Mukherjee, Tushar Kanti Maiti, Samir Bhattacharya, Santi P. Sinha Babu

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Designing AbhiSCoVac - A single potential vaccine for all ‘corona culprits’: Immunoinformatics and immune simulation approaches mā Abhigyan Choudhury, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Malay Kumar Rana, Suprabhat Mukherjee

I whakaputaina 2022

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Exploring the Binding Efficacy of Ivermectin Against the Key Proteins of SARS-CoV-2 Pathogenesis: an <i>in silico</i> Approach mā Abhigyan Choudhury, Nabarun Chandra Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan Chandra Patra, Suprabhat Mukherjee

I whakaputaina 2021

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics... mā Somrita Padma, Ritwik Patra, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Malay Kumar Rana, Suprabhat Mukherjee

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Rational design and computational evaluation of a multi-epitope vaccine for monkeypox virus: Insights into binding stability and immunological memory mā Anupamjeet Kaur, Amit Kumar, Geetika Kumari, Rasmiranjan Muduli, Mayami Das, Rakesh Kundu, Suprabhat Mukherjee, Tanmay Majumdar

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

In silico evidence of monkeypox F14 as a ligand for the human TLR1/2 dimer mā Ankita Chakraborty, Nabarun Chandra Das, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Malay Kumar Rana, Srinivasa Reddy Bonam, Jagadeesh Bayry, Suprabhat Mukherjee

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Protocol for designing a peptide-based multi-epitope vaccine targeting monkeypox using reverse vaccine technology mā Amit Kumar, Garima C. Nagar, Pradip K. Bhowmik, Geetika Kumari, Rasmiranjan Muduli, Mayami Das, Pritha Chakraborty, Anupamjeet Kaur, Kumari Shikha, Suprabhat Mukherjee, Rakesh Kundu, Indrakant K. Singh, Tanmay Majumdar

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Suprabhat Mukherjee

Toll-like Receptor 4 in COVID-19: Friend Or foe? mā Suprabhat Mukherjee

In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs mā Abhigyan Choudhury, Suprabhat Mukherjee

Targeting human TLRs to combat COVID‐19: A solution? mā Ritwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee

Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics Approach mā Ritwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee

Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma mā Ritwik Patra, Amit Kumar Dey, Suprabhat Mukherjee

TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review mā Suprabhat Mukherjee, Subhajit Karmakar, Santi P. Sinha Babu

Toll‐like receptor polymorphism in host immune response to infectious diseases: A review mā Suprabhat Mukherjee, Sahel Huda, Santi P. Sinha Babu

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein mā Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee

Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings mā Suprabhat Mukherjee, Nikhilesh Joardar, Subhasree Sengupta, Santi P. Sinha Babu

DPP-4 Inhibitors as a Savior for COVID-19 Patients with Diabetes mā Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu

Andrographolide Induces anti-SARS-CoV-2 Response Through host-directed Mechanism: an <i>in silico</i> Study mā B. S. Das, Nabarun Chandra Das, Shasank S. Swain, Suprabhat Mukherjee, Debapriya Bhattacharya

Wuchereria bancrofti filaria activates human dendritic cells and polarizes T helper 1 and regulatory T cells via toll-like receptor 4 mā Suprabhat Mukherjee, Anupama Karnam, Mrinmoy Das, Santi P. Sinha Babu, Jagadeesh Bayry

Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives mā Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, Andrea Masotti, Alessandro Paolini, Meysam Sarshar

A Novel Ligand of Toll-like Receptor 4 From the Sheath of Wuchereria bancrofti Microfilaria Induces Proinflammatory Response in Macrophages mā Suprabhat Mukherjee, Sandip Mukherjee, Tushar Kanti Maiti, Samir Bhattacharya, Santi P. Sinha Babu

Designing AbhiSCoVac - A single potential vaccine for all ‘corona culprits’: Immunoinformatics and immune simulation approaches mā Abhigyan Choudhury, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Malay Kumar Rana, Suprabhat Mukherjee

Exploring the Binding Efficacy of Ivermectin Against the Key Proteins of SARS-CoV-2 Pathogenesis: an <i>in silico</i> Approach mā Abhigyan Choudhury, Nabarun Chandra Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan Chandra Patra, Suprabhat Mukherjee

Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics... mā Somrita Padma, Ritwik Patra, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Malay Kumar Rana, Suprabhat Mukherjee

Rational design and computational evaluation of a multi-epitope vaccine for monkeypox virus: Insights into binding stability and immunological memory mā Anupamjeet Kaur, Amit Kumar, Geetika Kumari, Rasmiranjan Muduli, Mayami Das, Rakesh Kundu, Suprabhat Mukherjee, Tanmay Majumdar

In silico evidence of monkeypox F14 as a ligand for the human TLR1/2 dimer mā Ankita Chakraborty, Nabarun Chandra Das, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Malay Kumar Rana, Srinivasa Reddy Bonam, Jagadeesh Bayry, Suprabhat Mukherjee

Ngā utauta rapu:

Ngā marau whai pānga